COMPANIES COVERED
GlaxoSmithKlineDownload FREE Report Sample
Download Free sampleAmino Acid Metabolism Disorder Drug Market contains market size and forecasts of Amino Acid Metabolism Disorder Drug in Global, including the following market information:
Global Amino Acid Metabolism Disorder Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Amino Acid Metabolism Disorder Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Arginine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amino Acid Metabolism Disorder Drug include GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, DSM, Sanofi, Kyowa Hakko Kirin and BioMarin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amino Acid Metabolism Disorder Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amino Acid Metabolism Disorder Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Amino Acid Metabolism Disorder Drug Market Segment Percentages, by Type, 2021 (%)
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Sapropterin Dihydrochloride
Others
Global Amino Acid Metabolism Disorder Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Amino Acid Metabolism Disorder Drug Market Segment Percentages, by Application, 2021 (%)
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria
Global Amino Acid Metabolism Disorder Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Amino Acid Metabolism Disorder Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amino Acid Metabolism Disorder Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Amino Acid Metabolism Disorder Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
DSM
Sanofi
Kyowa Hakko Kirin
BioMarin
Swedish Orphan Biovitrum
Shine Star (Hubei) Biological Engineering
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
